Home › Companies › IOVANCE BIOTHERAPEUTICS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and IOVANCE BIOTHERAPEUTICS INC.’s Form 8-K, filed June 11, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 11, 2024: 11 items on IOVANCE BIOTHERAPEUTICS INC.’s Form 8-K, filed June 11, 2024: 4 approved · 7 passed (calculated).
Notable dissent: 1 director (14.5% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore IOVANCE BIOTHERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are IOVANCE BIOTHERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 11, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Dr. Dukes | 158,014,469 | -- | -- | 26,837,808 | 40,390,510 | 85% | Passed (calculated) | — |
| Elect Director: Dr. Countouriotis | 179,910,972 | -- | -- | 4,941,305 | 40,390,510 | 97% | Passed (calculated) | — |
| Elect Director: Mr. Maynard | 181,374,341 | -- | -- | 3,477,936 | 40,390,510 | 98% | Passed (calculated) | — |
| Elect Director: Mr. Rothbaum | 182,486,148 | -- | -- | 2,366,129 | 40,390,510 | 99% | Passed (calculated) | — |
| Elect Director: Dr. Vogt | 183,635,378 | -- | -- | 1,216,899 | 40,390,510 | 99.3% | Passed (calculated) | — |
| Elect Director: Dr. Weiser | 177,964,197 | -- | -- | 6,888,080 | 40,390,510 | 96% | Passed (calculated) | — |
| Elect Director: Ms. Yarno | 182,153,723 | -- | -- | 2,698,554 | 40,390,510 | 99% | Passed (calculated) | — |
| This proposal was approved with 173,751,712 "FOR" votes, 10,032,612 "AGAINST" votes and 1,067,953 "ABSTAIN" votes | 173,751,712 | 10,032,612 | 1,067,953 | -- | 40,390,510 | 95% | Approved | — |
| This proposal was approved with 223,631,459 "FOR" votes, 396,153 "AGAINST" votes and 1,215,175 "ABSTAIN" votes | 223,631,459 | 396,153 | 1,215,175 | -- | 0 | 99.8% | Approved | — |
| This proposal was approved with 177,464,536 "FOR" votes, 6,660,260 "AGAINST" votes and 727,481 "ABSTAIN" votes | 177,464,536 | 6,660,260 | 727,481 | -- | 40,390,510 | 96% | Approved | — |
| This proposal was approved with 182,042,189 "FOR" votes, 2,433,346 "AGAINST" votes and 376,742 "ABSTAIN" votes | 182,042,189 | 2,433,346 | 376,742 | -- | 40,390,510 | 99% | Approved | — |
Source: IOVANCE BIOTHERAPEUTICS INC., Form 8-K, filed with the SEC on June 11, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
271 asset managers disclosed a vote on at least one IOVANCE BIOTHERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of IOVANCE BIOTHERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Prior year: 89.1% for (June 6, 2023 meeting) ▲ 8.2 pts
Description as filed by funds: To elect seven directors named in the proxy statement accompanying this notice to serve until the 2025 Annual Meeting of Stockholders: Athena Countouriotis, M.D.
IOVANCE BIOTHERAPEUTICS INC.’s own tally for this item (“Elect Director: Dr. Countouriotis”): 179,910,972 for, 4,941,305 withheld, per its Form 8-K filed June 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 71 asset managers below reported 54,364,980 for, 569,542 withheld, 21,685 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 24,534,308 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,256,361 | 0 | 0 | 0 | For |
| BlackRock | 5,241,417 | 0 | 0 | 0 | For |
| State Street | 3,896,721 | 0 | 0 | 902 | For |
| Fidelity | 2,707,543 | 0 | 0 | 33,121 | For |
| Artisan | 2,609,946 | 0 | 0 | 0 | For |
| Charles Schwab | 1,923,319 | 0 | 0 | 0 | For |
| TIAA | 1,643,089 | 0 | 0 | 0 | For |
| Dimensional | 730,422 | 0 | 0 | 0 | For |
| Equitable | 397,643 | 0 | 0 | 261,740 | Mixed |
| Principal | 627,597 | 0 | 0 | 0 | For |
| JPMorgan | 456,188 | 0 | 0 | 0 | For |
| Goldman Sachs | 413,779 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 378,814 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 376,060 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 358,033 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 232,996 | 0 | 0 | 0 | For |
| Lincoln Financial | 223,364 | 0 | 0 | 0 | For |
| SEI | 205,227 | 0 | 0 | 0 | For |
| John Hancock | 200,228 | 0 | 0 | 0 | For |
| Virtus | 191,941 | 0 | 0 | 0 | For |
| ProShares | 141,508 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 135,954 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 96,595 | 0 | 21,685 | 0 | Mixed |
| Global X | 109,078 | 0 | 0 | 0 | For |
Showing the 25 largest of 71 asset managers. All 71 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Description as filed by funds: To elect seven directors named in the proxy statement accompanying this notice to serve until the 2025 Annual Meeting of Stockholders: Frederick G. Vogt, Ph.D., J.D.
IOVANCE BIOTHERAPEUTICS INC.’s own tally for this item (“Elect Director: Dr. Vogt”): 183,635,378 for, 1,216,899 withheld, per its Form 8-K filed June 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 71 asset managers below reported 54,956,207 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 24,534,308 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,256,361 | 0 | 0 | 0 | For |
| BlackRock | 5,241,417 | 0 | 0 | 0 | For |
| State Street | 3,897,623 | 0 | 0 | 0 | For |
| Fidelity | 2,740,664 | 0 | 0 | 0 | For |
| Artisan | 2,609,946 | 0 | 0 | 0 | For |
| Charles Schwab | 1,923,319 | 0 | 0 | 0 | For |
| TIAA | 1,643,089 | 0 | 0 | 0 | For |
| Dimensional | 730,422 | 0 | 0 | 0 | For |
| Equitable | 659,383 | 0 | 0 | 0 | For |
| Principal | 627,597 | 0 | 0 | 0 | For |
| JPMorgan | 456,188 | 0 | 0 | 0 | For |
| Goldman Sachs | 413,779 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 378,814 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 376,060 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 358,033 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 232,996 | 0 | 0 | 0 | For |
| Lincoln Financial | 223,364 | 0 | 0 | 0 | For |
| SEI | 205,227 | 0 | 0 | 0 | For |
| John Hancock | 200,228 | 0 | 0 | 0 | For |
| Virtus | 191,941 | 0 | 0 | 0 | For |
| ProShares | 141,508 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 135,954 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 118,280 | 0 | 0 | 0 | For |
| Global X | 109,078 | 0 | 0 | 0 | For |
Showing the 25 largest of 71 asset managers. All 71 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
Prior year: 87.3% for (June 6, 2023 meeting) ▼ 1.8 pts
Description as filed by funds: To elect seven directors named in the proxy statement accompanying this notice to serve until the 2025 Annual Meeting of Stockholders: Iain Dukes, D. Phil.
IOVANCE BIOTHERAPEUTICS INC.’s own tally for this item (“Elect Director: Dr. Dukes”): 158,014,469 for, 26,837,808 withheld, per its Form 8-K filed June 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 71 asset managers below reported 48,518,794 for, 5,808,744 withheld, 628,669 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 24,534,308 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,256,361 | 0 | 0 | 0 | For |
| BlackRock | 5,241,417 | 0 | 0 | 0 | For |
| State Street | 3,892,098 | 0 | 0 | 5,525 | For |
| Fidelity | 2,707,543 | 0 | 0 | 33,121 | For |
| Artisan | 0 | 0 | 0 | 2,609,946 | Withhold |
| Charles Schwab | 1,923,319 | 0 | 0 | 0 | For |
| TIAA | 1,643,089 | 0 | 0 | 0 | For |
| Dimensional | 730,422 | 0 | 0 | 0 | For |
| Equitable | 397,643 | 0 | 0 | 261,740 | Mixed |
| Principal | 545 | 0 | 0 | 627,052 | Withhold |
| JPMorgan | 0 | 0 | 456,188 | 0 | Abstain |
| Goldman Sachs | 413,779 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 378,814 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 376,060 | Withhold |
| Manager Directed Portfolios | 358,033 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 232,996 | Withhold |
| Lincoln Financial | 208,306 | 0 | 0 | 15,058 | Mixed |
| SEI | 0 | 0 | 0 | 205,227 | Withhold |
| John Hancock | 112,806 | 0 | 87,422 | 0 | Mixed |
| Virtus | 0 | 0 | 0 | 191,941 | Withhold |
| ProShares | 0 | 0 | 0 | 141,508 | Withhold |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 0 | 135,954 | Withhold |
| Bridge Builder Trust | 96,595 | 0 | 21,685 | 0 | Mixed |
| Global X | 0 | 0 | 0 | 109,078 | Withhold |
Showing the 25 largest of 71 asset managers. All 71 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Prior year: 87.0% for (June 6, 2023 meeting) ▲ 9.3 pts
Description as filed by funds: To elect seven directors named in the proxy statement accompanying this notice to serve until the 2025 Annual Meeting of Stockholders: Michael Weiser M.D., Ph.D.
IOVANCE BIOTHERAPEUTICS INC.’s own tally for this item (“Elect Director: Dr. Weiser”): 177,964,197 for, 6,888,080 withheld, per its Form 8-K filed June 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 71 asset managers below reported 54,364,980 for, 569,542 withheld, 21,685 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 24,534,308 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,256,361 | 0 | 0 | 0 | For |
| BlackRock | 5,241,417 | 0 | 0 | 0 | For |
| State Street | 3,896,721 | 0 | 0 | 902 | For |
| Fidelity | 2,707,543 | 0 | 0 | 33,121 | For |
| Artisan | 2,609,946 | 0 | 0 | 0 | For |
| Charles Schwab | 1,923,319 | 0 | 0 | 0 | For |
| TIAA | 1,643,089 | 0 | 0 | 0 | For |
| Dimensional | 730,422 | 0 | 0 | 0 | For |
| Equitable | 397,643 | 0 | 0 | 261,740 | Mixed |
| Principal | 627,597 | 0 | 0 | 0 | For |
| JPMorgan | 456,188 | 0 | 0 | 0 | For |
| Goldman Sachs | 413,779 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 378,814 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 376,060 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 358,033 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 232,996 | 0 | 0 | 0 | For |
| Lincoln Financial | 223,364 | 0 | 0 | 0 | For |
| SEI | 205,227 | 0 | 0 | 0 | For |
| John Hancock | 200,228 | 0 | 0 | 0 | For |
| Virtus | 191,941 | 0 | 0 | 0 | For |
| ProShares | 141,508 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 135,954 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 96,595 | 0 | 21,685 | 0 | Mixed |
| Global X | 109,078 | 0 | 0 | 0 | For |
Showing the 25 largest of 71 asset managers. All 71 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 90.8% for (June 6, 2023 meeting) ▲ 7.3 pts
Description as filed by funds: To elect seven directors named in the proxy statement accompanying this notice to serve until the 2025 Annual Meeting of Stockholders: Ryan Maynard
IOVANCE BIOTHERAPEUTICS INC.’s own tally for this item (“Elect Director: Mr. Maynard”): 181,374,341 for, 3,477,936 withheld, per its Form 8-K filed June 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 71 asset managers below reported 54,955,796 for, 411 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 24,534,308 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,256,361 | 0 | 0 | 0 | For |
| BlackRock | 5,241,417 | 0 | 0 | 0 | For |
| State Street | 3,897,212 | 0 | 0 | 411 | For |
| Fidelity | 2,740,664 | 0 | 0 | 0 | For |
| Artisan | 2,609,946 | 0 | 0 | 0 | For |
| Charles Schwab | 1,923,319 | 0 | 0 | 0 | For |
| TIAA | 1,643,089 | 0 | 0 | 0 | For |
| Dimensional | 730,422 | 0 | 0 | 0 | For |
| Equitable | 659,383 | 0 | 0 | 0 | For |
| Principal | 627,597 | 0 | 0 | 0 | For |
| JPMorgan | 456,188 | 0 | 0 | 0 | For |
| Goldman Sachs | 413,779 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 378,814 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 376,060 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 358,033 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 232,996 | 0 | 0 | 0 | For |
| Lincoln Financial | 223,364 | 0 | 0 | 0 | For |
| SEI | 205,227 | 0 | 0 | 0 | For |
| John Hancock | 200,228 | 0 | 0 | 0 | For |
| Virtus | 191,941 | 0 | 0 | 0 | For |
| ProShares | 141,508 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 135,954 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 118,280 | 0 | 0 | 0 | For |
| Global X | 109,078 | 0 | 0 | 0 | For |
Showing the 25 largest of 71 asset managers. All 71 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 90.8% for (June 6, 2023 meeting) ▲ 7.9 pts
Description as filed by funds: To elect seven directors named in the proxy statement accompanying this notice to serve until the 2025 Annual Meeting of Stockholders: Wayne P. Rothbaum
IOVANCE BIOTHERAPEUTICS INC.’s own tally for this item (“Elect Director: Mr. Rothbaum”): 182,486,148 for, 2,366,129 withheld, per its Form 8-K filed June 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 71 asset managers below reported 54,955,796 for, 411 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 24,534,308 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,256,361 | 0 | 0 | 0 | For |
| BlackRock | 5,241,417 | 0 | 0 | 0 | For |
| State Street | 3,897,212 | 0 | 0 | 411 | For |
| Fidelity | 2,740,664 | 0 | 0 | 0 | For |
| Artisan | 2,609,946 | 0 | 0 | 0 | For |
| Charles Schwab | 1,923,319 | 0 | 0 | 0 | For |
| TIAA | 1,643,089 | 0 | 0 | 0 | For |
| Dimensional | 730,422 | 0 | 0 | 0 | For |
| Equitable | 659,383 | 0 | 0 | 0 | For |
| Principal | 627,597 | 0 | 0 | 0 | For |
| JPMorgan | 456,188 | 0 | 0 | 0 | For |
| Goldman Sachs | 413,779 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 378,814 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 376,060 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 358,033 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 232,996 | 0 | 0 | 0 | For |
| Lincoln Financial | 223,364 | 0 | 0 | 0 | For |
| SEI | 205,227 | 0 | 0 | 0 | For |
| John Hancock | 200,228 | 0 | 0 | 0 | For |
| Virtus | 191,941 | 0 | 0 | 0 | For |
| ProShares | 141,508 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 135,954 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 118,280 | 0 | 0 | 0 | For |
| Global X | 109,078 | 0 | 0 | 0 | For |
Showing the 25 largest of 71 asset managers. All 71 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 87.3% for (June 6, 2023 meeting) ▲ 11.3 pts
Description as filed by funds: To elect seven directors named in the proxy statement accompanying this notice to serve until the 2025 Annual Meeting of Stockholders: Wendy Yarno
IOVANCE BIOTHERAPEUTICS INC.’s own tally for this item (“Elect Director: Ms. Yarno”): 182,153,723 for, 2,698,554 withheld, per its Form 8-K filed June 11, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 71 asset managers below reported 54,955,796 for, 411 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 24,534,308 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,256,361 | 0 | 0 | 0 | For |
| BlackRock | 5,241,417 | 0 | 0 | 0 | For |
| State Street | 3,897,212 | 0 | 0 | 411 | For |
| Fidelity | 2,740,664 | 0 | 0 | 0 | For |
| Artisan | 2,609,946 | 0 | 0 | 0 | For |
| Charles Schwab | 1,923,319 | 0 | 0 | 0 | For |
| TIAA | 1,643,089 | 0 | 0 | 0 | For |
| Dimensional | 730,422 | 0 | 0 | 0 | For |
| Equitable | 659,383 | 0 | 0 | 0 | For |
| Principal | 627,597 | 0 | 0 | 0 | For |
| JPMorgan | 456,188 | 0 | 0 | 0 | For |
| Goldman Sachs | 413,779 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 378,814 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 376,060 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 358,033 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 232,996 | 0 | 0 | 0 | For |
| Lincoln Financial | 223,364 | 0 | 0 | 0 | For |
| SEI | 205,227 | 0 | 0 | 0 | For |
| John Hancock | 200,228 | 0 | 0 | 0 | For |
| Virtus | 191,941 | 0 | 0 | 0 | For |
| ProShares | 141,508 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 135,954 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 118,280 | 0 | 0 | 0 | For |
| Global X | 109,078 | 0 | 0 | 0 | For |
Showing the 25 largest of 71 asset managers. All 71 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
100% of fund votes cast · no official result
Description as filed by funds: To approve an amendment to our 2020 Employee Stock Purchase Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder from 1,400,000 shares to 1,900,000 shares.
The 71 asset managers below reported 54,956,207 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 24,534,308 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,256,361 | 0 | 0 | 0 | For |
| BlackRock | 5,241,417 | 0 | 0 | 0 | For |
| State Street | 3,897,623 | 0 | 0 | 0 | For |
| Fidelity | 2,740,664 | 0 | 0 | 0 | For |
| Artisan | 2,609,946 | 0 | 0 | 0 | For |
| Charles Schwab | 1,923,319 | 0 | 0 | 0 | For |
| TIAA | 1,643,089 | 0 | 0 | 0 | For |
| Dimensional | 730,422 | 0 | 0 | 0 | For |
| Equitable | 659,383 | 0 | 0 | 0 | For |
| Principal | 627,597 | 0 | 0 | 0 | For |
| JPMorgan | 456,188 | 0 | 0 | 0 | For |
| Goldman Sachs | 413,779 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 378,814 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 376,060 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 358,033 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 232,996 | 0 | 0 | 0 | For |
| Lincoln Financial | 223,364 | 0 | 0 | 0 | For |
| SEI | 205,227 | 0 | 0 | 0 | For |
| John Hancock | 200,228 | 0 | 0 | 0 | For |
| Virtus | 191,941 | 0 | 0 | 0 | For |
| ProShares | 141,508 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 135,954 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 118,280 | 0 | 0 | 0 | For |
| Global X | 109,078 | 0 | 0 | 0 | For |
Showing the 25 largest of 71 asset managers. All 71 are in the interactive database (link above).
99.9% of fund votes cast · no official result
Description as filed by funds: To approve an amendment to our 2018 Equity Incentive Plan to increase the number of shares of the Company's common stock authorized for issuance thereunder from 29,700,000 shares to 36,700,000 shares and permit share recapture from our 2014 Equity Incentive Plan; and
The 65 asset managers below reported 52,551,314 for, 74,959 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 24,534,308 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,256,361 | 0 | 0 | 0 | For |
| BlackRock | 5,241,417 | 0 | 0 | 0 | For |
| State Street | 3,897,474 | 149 | 0 | 0 | For |
| Fidelity | 2,740,664 | 0 | 0 | 0 | For |
| Artisan | 2,609,946 | 0 | 0 | 0 | For |
| TIAA | 1,643,089 | 0 | 0 | 0 | For |
| Dimensional | 730,422 | 0 | 0 | 0 | For |
| Equitable | 659,383 | 0 | 0 | 0 | For |
| Principal | 627,052 | 0 | 0 | 0 | For |
| JPMorgan | 456,188 | 0 | 0 | 0 | For |
| Goldman Sachs | 413,779 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 378,814 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 376,060 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 358,033 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 232,996 | 0 | 0 | 0 | For |
| Lincoln Financial | 223,364 | 0 | 0 | 0 | For |
| John Hancock | 200,228 | 0 | 0 | 0 | For |
| Virtus | 191,941 | 0 | 0 | 0 | For |
| ProShares | 141,508 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 135,954 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 118,280 | 0 | 0 | 0 | For |
| Northern Trust | 102,522 | 0 | 0 | 0 | For |
| Prudential/PGIM | 100,186 | 0 | 0 | 0 | For |
| Pacific Life | 95,617 | 0 | 0 | 0 | For |
Showing the 25 largest of 65 asset managers. All 65 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
94% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: To approve, by non-binding advisory vote, the compensation of our named executive officers;
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 24,534,308 | 0 | 0 | 0 | For |
| Artisan | 6,318,874 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,256,361 | 0 | 0 | 0 | For |
| BlackRock | 5,241,417 | 0 | 0 | 0 | For |
| State Street | 3,896,721 | 902 | 0 | 0 | For |
| Fidelity | 2,740,664 | 0 | 0 | 0 | For |
| Charles Schwab | 1,923,319 | 0 | 0 | 0 | For |
| TIAA | 1,643,089 | 0 | 0 | 0 | For |
| Dimensional | 730,422 | 0 | 0 | 0 | For |
| Equitable | 659,383 | 0 | 0 | 0 | For |
| Principal | 627,597 | 0 | 0 | 0 | For |
| JPMorgan | 456,188 | 0 | 0 | 0 | For |
| Goldman Sachs | 413,779 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 378,814 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 376,060 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 358,033 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 232,996 | 0 | 0 | 0 | For |
| Lincoln Financial | 223,364 | 0 | 0 | 0 | For |
| SEI | 205,227 | 0 | 0 | 0 | For |
| John Hancock | 200,228 | 0 | 0 | 0 | For |
| Virtus | 191,941 | 0 | 0 | 0 | For |
| ProShares | 141,508 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 135,954 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 118,280 | 0 | 0 | 0 | For |
| Global X | 109,078 | 0 | 0 | 0 | For |
Fund voting reports, all 71 managers: 58,342,811 for, 322,324 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 8,714,455 | 0 | 0 | 0 | For |
| State Street | 8,205,731 | 1,142 | 0 | 0 | For |
| T. Rowe Price | 6,753,840 | 0 | 0 | 0 | For |
| BlackRock | 6,336,562 | 62,914 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 4,050,316 | 0 | 0 | 0 | For |
| Soleus Capital Management, L.P. | 3,992,028 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,956,146 | 0 | 0 | 0 | For |
| MPM BioImpact LLC | 2,200,000 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 2,191,484 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 2,116,403 | 0 | 0 | 0 | For |
| Charles Schwab | 1,923,564 | 0 | 0 | 0 | For |
| Nuveen | 1,658,152 | 0 | 0 | 0 | For |
| Northern Trust | 1,655,820 | 0 | 0 | 0 | For |
| UBS | 0 | 1,523,769 | 0 | 0 | Against |
| DE Shaw | 1,451,303 | 0 | 0 | 0 | For |
| Hood River Capital Management LLC | 1,431,274 | 0 | 0 | 0 | For |
| C WorldWide Asset Management Fondsmaeglerselskab A/S | 0 | 1,260,000 | 0 | 0 | Against |
| RICE HALL JAMES & ASSOCIATES, LLC | 22,454 | 1,194,385 | 0 | 0 | Against |
| NEW YORK STATE COMMON RETIREMENT FUND | 1,164,734 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 1,037,946 | 0 | 0 | 0 | For |
| Candriam S.C.A. | 0 | 909,180 | 0 | 0 | Against |
| Opaleye Management Inc. | 870,000 | 0 | 0 | 0 | For |
| Boxer Capital, LLC | 750,000 | 0 | 0 | 0 | For |
| 683 Capital Management, LLC | 737,178 | 0 | 0 | 0 | For |
| Goldman Sachs | 611,512 | 0 | 0 | 0 | For |
Institutional-manager reports, all 214 managers: 68,162,201 for, 7,461,970 against, 108,383 abstained. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
100% of fund votes cast · no official result
Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024;
The 71 asset managers below reported 54,956,207 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 24,534,308 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,256,361 | 0 | 0 | 0 | For |
| BlackRock | 5,241,417 | 0 | 0 | 0 | For |
| State Street | 3,897,623 | 0 | 0 | 0 | For |
| Fidelity | 2,740,664 | 0 | 0 | 0 | For |
| Artisan | 2,609,946 | 0 | 0 | 0 | For |
| Charles Schwab | 1,923,319 | 0 | 0 | 0 | For |
| TIAA | 1,643,089 | 0 | 0 | 0 | For |
| Dimensional | 730,422 | 0 | 0 | 0 | For |
| Equitable | 659,383 | 0 | 0 | 0 | For |
| Principal | 627,597 | 0 | 0 | 0 | For |
| JPMorgan | 456,188 | 0 | 0 | 0 | For |
| Goldman Sachs | 413,779 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 378,814 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 376,060 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 358,033 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 232,996 | 0 | 0 | 0 | For |
| Lincoln Financial | 223,364 | 0 | 0 | 0 | For |
| SEI | 205,227 | 0 | 0 | 0 | For |
| John Hancock | 200,228 | 0 | 0 | 0 | For |
| Virtus | 191,941 | 0 | 0 | 0 | For |
| ProShares | 141,508 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 135,954 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 118,280 | 0 | 0 | 0 | For |
| Global X | 109,078 | 0 | 0 | 0 | For |
Showing the 25 largest of 71 asset managers. All 71 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 279,756,339 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 8.77% |
| 2 | Artisan | 2.26% |
| 3 | T. Rowe Price | 1.88% |
| 4 | BlackRock | 1.87% |
| 5 | State Street | 1.39% |
| 6 | Fidelity | 0.98% |
| 7 | Charles Schwab | 0.69% |
| 8 | TIAA | 0.59% |
| 9 | Dimensional | 0.26% |
| 10 | Equitable | 0.24% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | PERCEPTIVE ADVISORS LLC | 3.12% |
| 2 | State Street | 2.93% |
| 3 | T. Rowe Price | 2.41% |
| 4 | BlackRock | 2.29% |
| 5 | Avoro Capital Advisors LLC | 1.45% |
| 6 | Soleus Capital Management, L.P. | 1.43% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.06% |
| 8 | MPM BioImpact LLC | 0.79% |
| 9 | PICTET ASSET MANAGEMENT SA | 0.78% |
| 10 | Palo Alto Investors LP | 0.76% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| New York, NY | 30,000,000 | 10.72% | Proxy statement (DEF 14A), proxy filed April 29, 2024 |
| Wayne Rothbaum | 30,000,000 | 10.72% | Proxy statement (DEF 14A), proxy filed April 29, 2024 |
| BlackRock | 25,956,289 | 9.28% | Form 13F, quarter ended March 31, 2024 |
| Vanguard Group | 24,058,983 | 8.60% | Form 13F, quarter ended March 31, 2024 |
| Malvern, PA | 22,812,820 | 8.15% | Proxy statement (DEF 14A), proxy filed April 29, 2024 |
| Boston, MA | 16,424,388 | 5.87% | Proxy statement (DEF 14A), proxy filed April 29, 2024 |
| State Street | 10,402,719 | 3.72% | Form 13F, quarter ended March 31, 2024 |
| Goldman Sachs | 6,575,502 | 2.35% | Form 13F, quarter ended March 31, 2024 |
| Morgan Stanley | 5,581,563 | 2.00% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 5,506,617 | 1.97% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 279,756,339 shares outstanding, as reported by IOVANCE BIOTHERAPEUTICS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At IOVANCE BIOTHERAPEUTICS INC.'s shareholder meeting held June 11, 2024, in the 2023-2024 proxy season, 271 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 2,620 separate fund positions. Their filings are grouped here into 11 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. IOVANCE BIOTHERAPEUTICS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, by non-binding advisory vote, the compensation of our named executive officers; — the reporting funds and managers cast 94% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from IOVANCE BIOTHERAPEUTICS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
IOVANCE BIOTHERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “IOVANCE BIOTHERAPEUTICS (IOVA) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/iovance-biotherapeutics-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.